News

Phone Interview Research Study AL, ATTR and AA Patients

Phone interview research for patients diagnosed with Amyloid Light-Chain(AL), Transyretin (TTR), or Amyloid Protein (AA) Systemic Amyloidosis

The purpose of this phone interview research study is to gather information about the symptoms and experiences of patients with Amyloid Light-Chain (AL), Transthyretin (TTR), or Amyloid A Protein (AA) Systemic Amyloidosis, in order to develop a questionnaire for future research studies. The interview would last approximately 75 minutes, and you would be compensated for your time. There is no medication administration involved with this study. This study will be conducted by ICON, a health research organization. This study is sponsored by GlaxoSmithKline. Please note that GlaxoSmithKline will not receive any identifying information, and any information that you provide will be reported in a way that protects your privacy and anonymity.

Contact:

If you live in the United States and would like more information about this study, please email Kelly Lipman at 0018-0665-AmyloidosisQual@iconplc.com  or call 1-866-893-0282.

AMYLOIDOSIS RESEARCH CONSORTIUM, INC.
320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170
22 (G1) FORTH STREET, EDINBURGH, UK EH1 3LH | +44 (0) 131 550 3866
arc@arci.org

ARC is a 501(c)(3) nonprofit organization